BT Wealth Management’s AbbVie ABBV Stock Holding History

BT Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$485K	Hold	3,166	–	–	0.14%	38
2022 Q1	$513K	Sell	3,166 -5,137	-62%	-$746K	0.13%	37
2021 Q4	$1.12M	Sell	8,303 -101	-1%	-$11.9K	0.3%	22
2021 Q3	$907K	Sell	8,404 -4,700	-36%	-$537K	0.28%	22
2021 Q2	$1.48M	Sell	13,104 -4,000	-23%	-$450K	0.45%	21
2021 Q1	$1.85M	Buy	17,104 +4,300	+34%	+$460K	0.62%	19
2020 Q4	$1.37M	Hold	12,804	–	–	0.51%	20
2020 Q3	$1.12M	Buy	12,804 +808	+7%	+$76.1K	0.49%	22
2020 Q2	$1.18M	Hold	11,996	–	–	0.6%	21
2020 Q1	$914K	Buy	11,996 +719	+6%	+$61.2K	0.52%	21
2019 Q4	$998K	Hold	11,277	–	–	0.51%	26
2019 Q3	$854K	Hold	11,277	–	–	0.48%	25
2019 Q2	$727K	Hold	11,277	–	–	0.42%	26
2019 Q1	$909K	Sell	11,277 -1,537	-12%	-$126K	0.54%	25
2018 Q4	$1.03M	Buy	+12,814	New	+$1.13M	0.44%	31

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BT Wealth Management's ABBV Position: Q2 2022 in Review

BT Wealth Management held its AbbVie (ABBV) position steady in Q2 2022 at 3,166 shares worth $485K. The position accounts for 0.14% of the portfolio, ranked #38.

BT Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 15 quarters since. The position peaked at $1.85M in Q1 2021. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

BT Wealth Management held 3,166 shares of AbbVie worth $485K as of Q2 2022.
BT Wealth Management left its AbbVie share count unchanged in Q2 2022.
AbbVie made up 0.14% of BT Wealth Management's portfolio in Q2 2022, its #38 holding.
BT Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 15 quarters since.
BT Wealth Management's AbbVie position peaked at $1.85M in Q1 2021.
3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on BT Wealth Management's 13F filing for Q2 2022, filed 15 Jul 2022.